The Journal of Japanese College of Angiology
Online ISSN : 1880-8840
Print ISSN : 0387-1126
ISSN-L : 0387-1126
Volume 62, Issue 8
Displaying 1-2 of 2 articles from this issue
Original Articles
  • Hidetoshi Oka, Yasunori Iida, Yu Inaba, Takahisa Miki, Takashi Hachiya
    2022 Volume 62 Issue 8 Pages 67-71
    Published: August 10, 2022
    Released on J-STAGE: August 10, 2022

    Thoracic endovascular aortic repair (TEVAR) still has many cut-down surgical approaches because of the large-size sheath. However, due to the lowering the profile of the device, Percutaneous TEVAR (P-TEVAR) using Preclosure ProGlide has also come to be performed. The merit of P-TEVAR is that it does not cause wound infection, lymphatic leakage, or femoral artery (FA) stenosis due to the cut-down method. Currently, the cases are limited in consideration of the physique, distance to FA from skin, and sheath size, but it is necessary to accumulate more cases in order to standardize P-TEVAR in the future.

    Download PDF (2906K)
  • Hideki Sakashita, Noriyuki Miyama, Nobuko Yamamoto, Masato Ohno, Yuka ...
    2022 Volume 62 Issue 8 Pages 73-77
    Published: August 10, 2022
    Released on J-STAGE: August 10, 2022

    Objective: We report here our experience with bovine pericardial patch (XenoSure), a new material for patch angioplasty during femoral artery thromboendarterectomy (TEA). Methods: Six patients (7 limbs) treated with TEA using XenoSure from September 2020 to March 2021 were included in the study. The mean age of the patients was 73.5 years, and the male to female ratio was 5 : 1. Five patients underwent TEA under general anesthesia, 1 patient under local anesthesia, and 3 patients received hybrid endovascular therapy (EVT). Results: The ankle-brachial pressure index recovered in all patients, and ischemic leg symptoms improved. Postoperative complications included one case of lymphatic leakage and one case of superficial wound infection; both recovered conservatively. Conclusions: The use of XenoSure in TEA not only leads to preservation of autologous veins and reduction of operative time, but also could enable reliable endarterectomy without the restriction on the length of the arteriotomy. Our results indicate that XenoSure could be a useful option in TEA.

    Download PDF (4217K)